Company / Gross Margin
AYTU BIOPHARMA, INC Gross Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
69.0%
FY2025
5-year range
44.5% / 75.3%
FY2021-FY2025
Trend
-8.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 62.0% to 69.0% over the past 2 years.
Based on SEC 10-K filings.
69.0% in FY2025 with a 5-year CAGR of -1.0%.
Improved from 62.0% to 69.0% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +15.0pp
- 5-Year Change
- -1.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin decreased 8.3% year-over-year.
- Peak gross margin was recorded in FY2024.
- Lowest gross margin in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 69.0% | -8.3% |
| FY2024 | 75.3% | +21.3% |
| FY2023 | 62.0% | +14.7% |
| FY2022 | 54.1% | +21.6% |
| FY2021 | 44.5% | -36.5% |
| FY2020 | 70.0% | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026